NFKB1 and malignant colon neoplasm: Moreover, the reduced NF-κB expression caused by the combinatorial treatment could well reflect an increased sensitization of surviving cells to the action of 5FU, as it is already reported that NF-κB inhibition helps to overcome resistance of colon cancer cells to 5FU [54].